首页> 外文期刊>Gene therapy >Gene-and cell-based bio-artificial pacemaker: What basic and translational lessons have we learned
【24h】

Gene-and cell-based bio-artificial pacemaker: What basic and translational lessons have we learned

机译:基于基因和细胞的生物人工起搏器:我们学到了哪些基础和翻译课程

获取原文
获取原文并翻译 | 示例
           

摘要

Normal rhythms originate in the sino-atrial node, a specialized cardiac tissue consisting of only a few thousands of nodal pacemaker cells. Malfunction of pacemaker cells due to diseases or aging leads to rhythm generation disorders (for example, bradycardias and sick-sinus syndrome (SSS)), which often necessitate the implantation of electronic pacemakers. Although effective, electronic devices are associated with such shortcomings as limited battery life, permanent implantation of leads, lead dislodging, the lack of autonomic responses and so on. Here, various gene-and cell-based approaches, with a particular emphasis placed on the use of pluripotent stem cells and the hyperpolarization-activated cyclic nucleotide-gated-encoded pacemaker gene family, that have been pursued in the past decade to reconstruct bio-artificial pacemakers as alternatives will be discussed in relation to the basic biological insights and translational regenerative potential.
机译:正常节律起源于窦房结,即仅由数千个节点起搏器细胞组成的特殊心脏组织。由于疾病或衰老导致的起搏器细胞功能失常会导致节律产生障碍(例如心动过缓和病窦综合征(SSS)),这通常需要植入电子起搏器。尽管有效,但是电子设备还具有诸如电池寿命有限,引线永久植入,引线脱落,缺乏自主响应等缺点。在这里,过去十年来一直在寻求各种基于基因和细胞的方法,其中特别着重于利用多能干细胞和超极化激活的环状核苷酸门控编码的起搏器基因家族。人工起搏器作为替代方案,将与基本生物学见解和转化再生潜能相关地进行讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号